Jasmine and Jordan Davis were both born with sickle cell disease. As children, they endured painful sickle cell crises and frequent hospital visits, often relying on blood transfusions and red cell exchanges to ease their symptoms. In 2019, both siblings became eligible for bone marrow transplants — a procedure that would replace their bone marrow producing sickle cells with bone marrow producing healthy red blood cells and cure their sickle cell disease. Jasmine received stem cells from her mother, and Jordan from his father. Blood and platelet transfusions played a critical role in supporting their bodies through the intense treatment and recovery. “Before the transplant, I had appointments with different specialists to make sure my body and systems could tolerate the transplant,” Jasmine said. “I had four kinds of chemotherapy and full body radiation to kill off the bad bone marrow and get me ready for the transplant. I was in the hospital for a month and a half. It took a while ...